US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2022-01-28T00:00:00
Lansoprazole Delayed-Release Orally Disintegrating Tablets in dosage form
Lansoprazole, imported in 15 mg and 30 mg delayed-release (DR) tablets, is a proton-pump inhibitor (PPI). It is used to reduce gastric acid secretion and for the short term treatment of active gastric ulcers, active duodenal ulcers, erosive reflux oesophagitis, symptomatic gastroesophageal reflux disease, and non-steroidal anti-inflammatory drug (NSAID) induced gastric and duodenal ulcers.
Description : Lansoprazole Delayed-Release Orally Disintegrating Tablets in dosage form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :